New Insights into the Neurobiology of Restless Legs Syndrome
- PMID: 30047288
- PMCID: PMC9372713
- DOI: 10.1177/1073858418791763
New Insights into the Neurobiology of Restless Legs Syndrome
Abstract
Restless legs syndrome (RLS) is a common sensorimotor disorder, whose basic components include a sensory experience, akathisia, and a sleep-related motor sign, periodic leg movements during sleep (PLMS), both associated with an enhancement of the individual's arousal state. The present review attempts to integrate the major clinical and experimental neurobiological findings into a heuristic pathogenetic model. The model also integrates the recent findings on RLS genetics indicating that RLS has aspects of a genetically moderated neurodevelopmental disorder involving mainly the cortico-striatal-thalamic-cortical circuits. Brain iron deficiency (BID) remains the key initial pathobiological factor and relates to alterations of iron acquisition by the brain, also moderated by genetic factors. Experimental evidence indicates that BID leads to a hyperdopaminergic and hyperglutamatergic states that determine the dysfunction of cortico-striatal-thalamic-cortical circuits in genetically vulnerable individuals. However, the enhanced arousal mechanisms critical to RLS are better explained by functional changes of the ascending arousal systems. Recent experimental and clinical studies suggest that a BID-induced hypoadenosinergic state provides the link for a putative unified pathophysiological mechanism for sensorimotor signs of RLS and the enhanced arousal state.
Keywords: adenosine; arousal; brain iron deficiency; dopamine; glutamate; restless legs syndrome.
Conflict of interest statement
Declaration of Conflicting Interests
The authors declare no conflict of interests
Figures
References
-
- Aksu M, Bara-Jimenez W. 2002. State dependent excitability changes of spinal flexor reflex in patients with restless legs syndrome secondary to chronic renal failure. Sleep Med 3:427–30. - PubMed
-
- Allen RP, Mignot E, Ripley B, Nishino S, Earley CJ. 2002. Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome. Neurology 59:639–41. - PubMed
-
- Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, and others. 2005. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 165:1286–92. - PubMed
-
- Allen RP, Earley CJ. 2007. The role of iron in restless legs syndrome. Mov Disord 18:S440–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
